N America

North America equity research

Explore the most viewed and latest equity research and media content we have for listed companies based in North America.

U.S. Equity Research

Broker research, valuations, and analysis on American stocks

24 Apr 18

Executive interview - Takung Art

01 Nov 17

TAG Oil - Update from 121 Oil and Gas, London

21 Mar 18

Bitesize briefing – Vermillion Energy

23 May 17

Capital Network's James Dolman on Midpoint Holdings Ltd

08 Sep 16

EXTENDED Executive Interview with VolitionRX’s CEO Cameron Reynolds

29 Nov 16

Executive Interview - Canacol

26 Feb 18

VolitionRx Limited Announces Interim Results from 680-Subject Clinical Trial in Colorectal Cancer

19 Apr 16

JP Morgan - Update at 121 Mining Investment

14 Mar 17

Executive Interview - VolitionRx

19 Apr 16

Corvus Gold Inc - Update at 121 Mining Investment

20 Mar 18

VolitionRx: Results from asymptomatic CRC trial reported

15 Feb 16

Plateau Uranium - Update at 121 Mining Investment

02 Mar 18

VolitionRX reports their Full Year 2017 Earnings

15 Feb 16

Monument Mining - Update at 121 Mining Investment

20 Nov 17

Executive interview - VolitionRx

Latest Content

TAKUNG ART CO

Takung Art - Growing the retail base

Takung Art’s Q118 results show it is making progress at reorienting its user base more towards the retail market, which significantly increases its potential reach. There has also been some success in the quarter in increasing the average listing values of the items listed on the trading platform and in diversifying the offering, with five new pieces of sports memorabilia listed in the period. The FY17 reconstruction makes direct comparison with Q117 figures of limited use. The share price is yet to reflect the scale or quality of the potential opportunity.

View

22 May 18
-
-

PDL BIOPHARMA

PDL BioPharma - First quarter results

PDL’s recent Q118 results reported that revenues of $38.5m were down 15.2% compared to Q117 as the company transitioned away from royalties related to the Queen et al. patents to product revenue related to its Noden and LENSAR subsidiaries as well as royalties from the Depomed assets. Excluding Queen et al. royalties, revenues were up 14.2%. Also, while the revenues associated with the Tekturna assets sold by Noden continue to be weak, LENSAR is now EBITDA positive. PDL has also repurchased approximately $12.6m of stock since March 2018 and has $12.4m available under its current repurchase program.

View

22 May 18
-
-

FRR NOG SEN ZOL SDX

GMP FirstEnergy ― UK Energy morning research package

Jadestone Energy (JSE CN); Speculative Buy, C$1.00: Update on new contract for Ogan Komering, Indonesia | Frontera Resources (FRR LN) (not covered): Operating update in Georgia | Nostrum Oil & Gas (NOG LN)6; BUY, £4.50: 1Q18 results & production guidance reduction | Serinus Energy (SENX LN/SEN CN)1: Speculative Buy, £0.25; Moftinu–1007 well spud in Romania | Zoltav Resources (ZOL LN) (not covered): Final results | SDX Energy (SDX LN/CN)1,6: BUY, £0.80; Kelvin-1X exploration well result, Egypt

View

22 May 18
-
-

Kosmos Energy SERINUS ENERGY

GMP FirstEnergy ― UK Energy morning research package

Kosmos Energy (KOS US/LN) (not covered): Well update in Suriname | Serinus Energy (SEN LN/CN)1 : Speculative Buy, £0.25; Coming closer to home

View

21 May 18
-
-

SLG GENL SDX

GMP FirstEnergy ― UK Energy morning research package

Sterling Resources (SLG CN) (not covered): Operations update in Peru | La Francaise de l’Energie (LFDE FP)6 ; Speculative Buy, EUR40.00: 1Q18 revenue | Genel Energy (GENL LN); REDUCE, £1.80: Kurdistan update | SDX Energy (SDX LN/CN)1,6: BUY, £0.80; 1Q18 results | Total (FP FP) (not covered): Withdrawal from Iran project

View

17 May 18
-
-

CNE TXP PMO CAD ELA

GMP FirstEnergy ― UK Energy morning research package

Canacol Energy (CNE CN) (not covered): 1Q18 result | Touchstone Exploration (TXP CN)1,6 ; BUY, C$0.60: 1Q18 results and drilling program could potentially increase production | Premier Oil (PMO LN); BUY, £1.30: 1Q18 trading update | Cadogan Petroleum (CAD LN) (not covered): Delayed approval of the application to renew Ukraine Licence | Eland Oil & Gas (ELA LN) (not covered): Opuama-9 well, OML 40, in Nigeria

View

16 May 18
-
-

CNE CPI TETY OPHR

GMP FirstEnergy ― UK Energy morning research package

Cairn Energy (CNE LN); BUY, £2.60: AGM statement | Condor Petroleum (CPI CN) (not covered): 1Q18 results | Tethys Oil (TETY SS): BUY, SEK85; Exploration strategy already delivering results | Ophir Energy (OPHR LN); HOLD, £0.70: Risk of losing FLNG project?

View

15 May 18
-
-

Perpetual Energy

FLASH: Announces disposition

Perpetual announced that it has closed the disposition of noncore royalty interests in eastern Alberta for gross proceeds of $10.0 mm. The effective date of the transaction is May 1, 2018.

View

15 May 18
-
-

INTERNATIONAL STEM CELL

Moving forward in Parkinsons and TBI

International Stem Cell (ISCO) is an early-stage cell therapy company currently in clinical trials to treat Parkinson’s disease (PD). In November, the company presented interim six-month results from the first cohort of four patients in its Phase I trial of ISC-hpNSC in PD. Positive signals were seen in a variety of measures, which include daily living, mobility, depression and compulsive disorders.

View

14 May 18
-
-

VLE UEN SDX TGL AOI

GMP FirstEnergy ― UK Energy morning research package

Valeura Energy (VLE CN)1,6; BUY, C$11.50: Program to appraise and de-risk the basin centered natural gas accumulation on track | Urals Energy (UEN LN) (not covered): YE17 reserves & resources CPR | SDX Energy (SDX LN/CN): BUY, £0.80; Private investor call | TransGlobe Energy (TGL CN); BUY, C$3.75: 1Q18 results and potentially meaningful exploration drilling upcoming | Africa Oil (AOI CN/SS): BUY, C$2.20; 1Q18 results |

View